The Beers criteria: Not just for geriatrics anymore? Analysis of Beers criteria medications in nongeriatric trauma patients and their association with falls. Issue 1 (July 2019)

• Record Type: Journal Article
• Authors: Maerz, Adam H.; Walker, Benjamin S.; Collier, Bryan R.; Tegge, Allison N.; Faulks, Emily R.; Bower, Katie L.; Nussbaum, Michael S.; Lollar, Daniel I.; Hamill, Mark E.
• Is Part Of: Journal of trauma and acute care surgery. Volume 87:Issue 1(2019)
• Publication Date: 2019-07
• Subjects: Falls -- potentially inappropriate medications -- adults -- epidemiology; Surgical intensive care -- Periodicals; Surgical emergencies -- Periodicals; Wounds and injuries -- Surgery -- Periodicals; 617.026
• DOI: 10.1097/TA.0000000000002280
• Languages: English
• ISSNs: 2163-0755

Abstract

Abstract : BACKGROUND: It has been well established that many classes of medications on the Beers list of Potentially Inappropriate Medications (PIMs) are associated with falls and injuries in the geriatric population, but little work has been performed to understand if similar relationships exist among the nongeriatric adult population. METHODS: A retrospective chart review of 32 months of trauma encounters at our Level I trauma center was performed in nongeriatric adults aged 18 years to 64 years. Encounters were reviewed by mechanism of injury and intake medication reconciliation. The data were then evaluated for associations between PIMs and falls. RESULTS: Of the 7, 897 trauma encounters in the study period, 6, 493 had completed medication reconciliation, and 4, 154 were between the ages of 18 years and 64 years. There was a statistically significant disproportionate number of those who sustained a fall on psychoactive medications and proton pump inhibitors, and the odds of a trauma patient presenting as a fall were also significantly higher on these select classes of PIMs. CONCLUSION: The PIMs associated with falls in the geriatric population are also associated with falls in the nongeriatric population. This study supports the judicious prescribing of these medications, as they may have risks beyond what was originally thought. LEVEL OF EVIDENCE: Prognostic, level IV.